- AuthorisedTherapeutic confirmatory (Phase III)
Single-blinded randomized investigator-initiated controlled trial to assess the efficacy of colchicine to treat patients with cardiomyopathy with myocarditis (chronic inflammatory cardiomyopathy) – Trial and Registry to study the role of genotype environment interaction in Chronic myocarditis and inflammatory cardiomyopathies with ventricular pro-arrhythmic and heart failure phenotypes (PNRR-MAD-2022-12376225)
This study is looking at whether a medicine called colchicine can help people with an inflammatory heart condition. It aims to see if the medicine can prevent the condition from getting worse and help improve heart health over six months.
For: Inflammatory cardiomyopathyItaly - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Oxaliplatin-based Chemotherapy for Treatment of Gastrointestinal, Pancreatic, or Colorectal Cancer (RECITE)
This study looks at a new medicine called Romiplostim for people with certain cancers who are having chemotherapy. It aims to see if Romiplostim can help prevent low platelet counts, which are tiny blood cells important for stopping bleeding, caused by chemotherapy.
For: Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal · Pancreatic · or Colorectal CancerSpain · Portugal · France